AbCellera Biologics logo

AbCellera Biologics

ID: 5331849

Vancouver-based company focused on antibody discovery for therapeutics and immune profiling for vaccine research.

11

Funding Rounds

$378.9m

Money raised

Overview

Vancouver-based company focused on antibody discovery for therapeutics and immune profiling for vaccine research.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company AbCellera Biologics has raised a total of $296.22m in funding over 11 rounds.

Key Insights:

  • AbCellera Biologics Series B round, May 27, 2020: $105m
  • AbCellera Biologics Grant (money), May 3, 2020: $175.6m
  • AbCellera Biologics Grant (money), May 14, 2019: $4.8m
  • AbCellera Biologics Series A round: $10m
  • AbCellera Biologics venture round, April 2017 : $817.9k
  • AbCellera Biologics Inc. funding round, May 2020: $74.5m
  • AbCellera Biologics Inc. funding round, August 2018: $7.7m
  • AbCellera Biologics Inc. funding round, March 2018: $484.48k